Evidence demonstrates that vaspin has correlation with many metabolic diseases, such as obesity, diabetes, and metabolic syndrome, and its level is positively correlated with the risk of many vascular and metabolic dysfunctions [16, 17], so it may be used as a biomarker for MAFLD. The gene discussed is SERPINA12; the disease is metabolic disease.